OSSIO

Intelligent Bone Implant Technology

Health Tech & Life Sciences
Active
Series D Caesarea Founded 2014
Total raised
$90.1M
Last: Debt Financing 2026-02
Stage
Series D
Founded
2014
Headcount
139
HQ
Caesarea
Sector
Health Tech & Life Sciences

About

OSSIO is an orthopedic company providing an innovative alternative to metal implants in the more than $10 billion orthopedic fixation market with its intelligent bone implant technology. OSSIOfiber is a biofriendly implant material that is stronger than cortical bone and leaves nothing permanent behind. Stemming from years of biomechanical research and a vision for the possibility of better bone healing, OSSIOfiber is engineered to provide the strength required for functional fixation and allows for full integration into the native anatomy without adverse inflammation. OSSIOs proprietary technology can address many surgical applications through the manufacture of endless implant designs. In addition, OSSIOfiber implants utilize existing reimbursement and surgical techniques.

Funding history · 4 rounds · $90.1M total

2026-02
Debt Financing $50.0M
2024-12
Series D $27.6M
2022-10
Series C $38.5M
2019-03
Series A $22.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

orthopedicssurgeonsbiomaterialspatent-pendingdoctorshealthcare-providershospitalsrehabilitationregenerative-medicinemedical-productsclinicssurgerymedical-technologies